-
AVEO Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Aveo Pharmaceuticals (AVEO)
Company Profile
Quarter (USD) | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 77.40 mm | 77.40 mm | 77.40 mm | 77.40 mm | 77.40 mm | 77.40 mm |
Cash burn (monthly) | (no burn) | (no burn) | 722.67 k | 2.04 mm | (no burn) | 1.89 mm |
Cash used (since last report) | n/a | n/a | 19.38 mm | 54.74 mm | n/a | 50.64 mm |
Cash remaining | n/a | n/a | 58.02 mm | 22.66 mm | n/a | 26.75 mm |
Runway (months of cash) | n/a | n/a | 80.3 | 11.1 | n/a | 14.2 |
13F holders | Current |
---|---|
Total holders | 2 |
Opened positions | 0 |
Closed positions | 110 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 28.42 mm |
Total shares | 6.34 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Growth Equity Opportunities Fund IV | 5.42 mm | $28.42 mm |
Hirschman Orin | 920.36 k | $0.00 |